IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

A newly designed therapy following an islet cell transplant could mean people with type 1 diabetes no longer need to inject ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

CHICAGO (CBS) – A groundbreaking treatment for type 1 diabetes is showing promising results for patients in Chicago. It's a ...

and sometimes people are told to change their diabetes treatment. If you or your family member start a new diabetes treatment, make sure to ask the right questions from the doctor. Let us tell you ...

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal ...

A collaboration of researchers led by Emory University Rollins School of Public Health, Atlanta, is urging caution when ...